Overview

Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Study in healthy volunteers to investigate the effects of Rifampin on the Pharmacokinetics of NKTR-118.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Naloxegol
Rifampin